Sinovial® One is a buffered physiological solution of sodium salt hyaluronic acid, endowed with viscoelastic properties.
Sinovial® One contains 2.0% highly purified hyaluronic acid sodium salt, with a molecular weight between 800 and 1200 kDalton.
Its other ingredients are sodium chloride, sodium phosphate and water for injections.
Hyaluronic acid sodium salt (hyaluronan*) consists of iterative chains of disaccharide units of N-acetylglucosamine and sodium glucuronate. It constitutes an essential component of the synovial fluid to which it confers its viscoelastic properties.
The sodium salt hyaluronic acid contained in Sinovial® One is obtained by fermentation and without having undergone any chemical modification.
Class III medical device. CE0373 marking.
*Another designation often used.
Packaging available
Box with 1 glass pre-filled syringe (50.0 mg of hyaluronic acid sodium salt in 2.5 ml of physiological solution buffered with sodium chloride) and 1 needle 21 G x 1½" (0.8 x 40 mm).
The contents of the pre-filled syringe have been steam sterilized.
The needle was sterilized with ethylene oxide.
Sinovial® One is a buffered physiological solution of sodium salt hyaluronic acid, endowed with viscoelastic properties.
Sinovial® One contains 2.0% highly purified hyaluronic acid sodium salt, with a molecular weight between 800 and 1200 kDalton.
Its other ingredients are sodium chloride, sodium phosphate and water for injections.
Hyaluronic acid sodium salt (hyaluronan*) consists of iterative chains of disaccharide units of N-acetylglucosamine and sodium glucuronate. It constitutes an essential component of the synovial fluid to which it confers its viscoelastic properties.
The sodium salt hyaluronic acid contained in Sinovial® One is obtained by fermentation and without having undergone any chemical modification.
Class III medical device. CE0373 marking.
*Another designation often used.
Packaging available
Box with 1 glass pre-filled syringe (50.0 mg of hyaluronic acid sodium salt in 2.5 ml of physiological solution buffered with sodium chloride) and 1 needle 21 G x 1½" (0.8 x 40 mm).
The contents of the pre-filled syringe have been steam sterilized.
The needle was sterilized with ethylene oxide.
Indication
Pain or reduced mobility due to degenerative diseases (osteoarthritis), post-traumatic diseases or alterations in the joint and tendons.
Sinovial® One is an appropriate joint fluid substitution agent that restores the physiological and rheological conditions of osteoarthritic joints.
This therapeutic action is based on the particular properties exerted by the hyaluronic acid used.
The hyaluronic acid contained in Sinovial® One, obtained by fermentation and chemically unmodified, is extremely well tolerated.
By restoring the viscoelastic properties of joint fluid, Sinovial® One reduces pain and restores joint and tendon mobility.
Sinovial® One only acts in the joint into which it was injected and has no systemic effect.
Sinovial® One is a single dose preparation and should be injected only once per treatment cycle. Injections can be made later if necessary. The advisability and the frequency with which the treatment cycle can be repeated must be evaluated by the doctor for each patient individually, taking into consideration for each case the benefit/risk ratio of the treatment.
Sinovial® One is also indicated for acute and chronic tendinopathies and/or associated with articular alterations and in the tendon repair process, even after surgery. Sinovial® One is a medical device designed to integrate synovial fluid and restores the physiological and rheological properties of arthritic joints and tendons. In the joints, Sinovial® One reduces pain and promotes the restoration of joint and tendon mobility, acting only at the level of the synovial cavity in which it is injected without systemic action.
In addition, Sinovial® One, thanks to its lubricating and viscoelastic properties, acts at the level of the tendon sheath where it improves the sliding of the tendon and the physiological healing/repair processes, thus preventing the formation of adhesions during the post-operative course. operative.
Pain or reduced mobility due to degenerative diseases (osteoarthritis), post-traumatic diseases or alterations in the joint and tendons.
Sinovial® One is an appropriate joint fluid substitution agent that restores the physiological and rheological conditions of osteoarthritic joints.
Sinovial® One is a buffered physiological solution of sodium salt hyaluronic acid, endowed with viscoelastic properties.
Sinovial® One contains 2.0% highly purified hyaluronic acid sodium salt, with a molecular weight between 800 and 1200 kDalton.
Its other ingredients are sodium chloride, sodium phosphate and water for injections.
Hyaluronic acid sodium salt (hyaluronan*) consists of iterative chains of disaccharide units of N-acetylglucosamine and sodium glucuronate. It constitutes an essential component of the synovial fluid to which it confers its viscoelastic properties.
The sodium salt hyaluronic acid contained in Sinovial® One is obtained by fermentation and without having undergone any chemical modification.
Class III medical device. CE0373 marking.
*Another designation often used.
Packaging available
Box with 1 glass pre-filled syringe (50.0 mg of hyaluronic acid sodium salt in 2.5 ml of physiological solution buffered with sodium chloride) and 1 needle 21 G x 1½" (0.8 x 40 mm).
The contents of the pre-filled syringe have been steam sterilized.
The needle was sterilized with ethylene oxide.
Sinovial® One is a buffered physiological solution of sodium salt hyaluronic acid, endowed with viscoelastic properties.
Sinovial® One contains 2.0% highly purified hyaluronic acid sodium salt, with a molecular weight between 800 and 1200 kDalton.
Its other ingredients are sodium chloride, sodium phosphate and water for injections.
Hyaluronic acid sodium salt (hyaluronan*) consists of iterative chains of disaccharide units of N-acetylglucosamine and sodium glucuronate. It constitutes an essential component of the synovial fluid to which it confers its viscoelastic properties.
The sodium salt hyaluronic acid contained in Sinovial® One is obtained by fermentation and without having undergone any chemical modification.
Class III medical device. CE0373 marking.
*Another designation often used.
Packaging available
Box with 1 glass pre-filled syringe (50.0 mg of hyaluronic acid sodium salt in 2.5 ml of physiological solution buffered with sodium chloride) and 1 needle 21 G x 1½" (0.8 x 40 mm).
The contents of the pre-filled syringe have been steam sterilized.
The needle was sterilized with ethylene oxide.
Indication
Pain or reduced mobility due to degenerative diseases (osteoarthritis), post-traumatic diseases or alterations in the joint and tendons.
Sinovial® One is an appropriate joint fluid substitution agent that restores the physiological and rheological conditions of osteoarthritic joints.
This therapeutic action is based on the particular properties exerted by the hyaluronic acid used.
The hyaluronic acid contained in Sinovial® One, obtained by fermentation and chemically unmodified, is extremely well tolerated.
By restoring the viscoelastic properties of joint fluid, Sinovial® One reduces pain and restores joint and tendon mobility.
Sinovial® One only acts in the joint into which it was injected and has no systemic effect.
Sinovial® One is a single dose preparation and should be injected only once per treatment cycle. Injections can be made later if necessary. The advisability and the frequency with which the treatment cycle can be repeated must be evaluated by the doctor for each patient individually, taking into consideration for each case the benefit/risk ratio of the treatment.
Sinovial® One is also indicated for acute and chronic tendinopathies and/or associated with articular alterations and in the tendon repair process, even after surgery. Sinovial® One is a medical device designed to integrate synovial fluid and restores the physiological and rheological properties of arthritic joints and tendons. In the joints, Sinovial® One reduces pain and promotes the restoration of joint and tendon mobility, acting only at the level of the synovial cavity in which it is injected without systemic action.
In addition, Sinovial® One, thanks to its lubricating and viscoelastic properties, acts at the level of the tendon sheath where it improves the sliding of the tendon and the physiological healing/repair processes, thus preventing the formation of adhesions during the post-operative course. operative.
Pain or reduced mobility due to degenerative diseases (osteoarthritis), post-traumatic diseases or alterations in the joint and tendons.
Sinovial® One is an appropriate joint fluid substitution agent that restores the physiological and rheological conditions of osteoarthritic joints.
Réf. : 048660